Piramal’s project will support 195 jobs, unlocking new market opportunities and strengthening the sector’s competitiveness
| NEWS | September 17, 2026 |
AURORA —The Ontario government is investing $1,753,620 through the Life Sciences Scale-Up Fund (LSSUF) to enable Piramal Pharma to upgrade its site infrastructure and commercialize their Ontario-made health technologies to new markets.
Piramal is investing $5,314,000 to upgrade its site infrastructure at their Aurora facility, strengthening Ontario’s pharmaceutical manufacturing and boosting domestic production of APIs. This project will enhance R&D and clinical API production, boosting domestic manufacturing, ensuring the commercial availability of critical drug substances, and reducing reliance on foreign suppliers, to support a resilient, and globally competitive life sciences industry in Ontario. The investment will create 12 new, good-paying jobs and protect 183 existing positions.
“Through the Life Sciences Scale-Up Fund, our government is ensuring that Ontario businesses are positioned to develop, commercialize and deploy new technologies across the health-care system,” said Dawn Gallagher Murphy, Member of Provincial Parliament for Newmarket—Aurora. “With this investment, Piramal will be positioned to turn their latest ideas into market-ready solutions, all while creating good-paying jobs and reinforcing Ontario’s position as global biomanufacturing and life sciences hub.”
First launched in 2024, the $24 million LSSUF works in tandem with the government’s Health Innovation Pathway to advance the objectives of Phase 2 of Ontario’s Life Sciences Strategy and strengthen Ontario’s position as a global leader in health innovation.
“We are grateful to the Government of Ontario and MPP Dawn Gallagher Murphy for their support of this important investment in our Aurora facility,” said Peter DeYoung, CEO, Piramal Global Pharma. “This funding will help enable Piramal Pharma Solutions to upgrade our site infrastructure, strengthen our manufacturing capabilities, and enhance our ability to serve patients and customers around the world. In addition to supporting business growth, this investment will help advance projects focused on sustainability, operational efficiency, and the modernization of our site, reinforcing our commitment to responsible manufacturing and environmental stewardship.”
To build on the momentum of the fund’s initial success, the 2026 Ontario Budget invested an additional $24 million dedicated to supporting Ontario companies whose work will accelerate the adoption of innovative technologies into the health-care system and support the province’s broader vision to provide connected, convenient care closer to home.
“Ontario’s life sciences sector plays a critical role in supporting the discovery and development of innovative medicines and technologies, which is why our government is proud to support local companies as they take their Ontario-made products to the next level,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “By investing in Piramal through the Life Sciences Scale-Up Fund, we are scaling up our province’s domestic capacity while further positioning Ontario as a leading jurisdiction for life sciences investment for generations to come.”
By helping small and medium-sized Ontario companies scale, commercialize their health innovations and build domestic manufacturing capacity, the government is strengthening Ontario’s leadership in the life sciences and advancing next-generation technologies across the health-care supply chain.
QUICK FACTS
- With the first round of funding now fully deployed, the LSSUF program has officially leveraged nearly $75 million in investment, supporting over 1,000 good-paying jobs across 14 projects.
- Ontario’s life sciences sector employs close to 76,000 people in good-paying jobs across over 2,000 companies, with annual exports exceeding $14 billion.
- Since 2018, Ontario has attracted over $6 billion in life sciences investments to the province.
- The LSSUF works in tandem with the Health Innovation Pathway to help Ontario innovators bring solutions to the provincial health-care system faster.
- In 2024-2025, over 94,000 STEM students graduated from post-secondary programs across the province, producing one of the most highly skilled life sciences workforces in the world.
- In April 2025, the government announced an investment of $750 million to expand enrolment in STEM programs at colleges and universities by up to 20,500 seats per year.